Schedule 2 to the Principal Order is amended as follows:

(a) by inserting after item 2037 the following:

2037M.

Diclofenac in divided preparations for oral use containing 12.5mg or less of diclofenac per dosage unit in a pack containing 20 or fewer dosage units and labelled with a recommended daily dose of 75mg or less of diclofenac.

(b) by omitting item 2068 and substituting the following:

2068.	Ibuprofen in preparations for oral use when labelled with a recommended daily dose of 1 200mg or less of ibuprofen –
	(a) in liquid preparations when sold in the manufacturer's original pack containing 4g or less of ibuprofen; or
	(b) in divided preparations, each containing 200mg or less of ibuprofen, in packs of 100 or fewer dosage units except when –
	(i) as the only therapeutically active constituent other than an effervescent agent; and
	(ii) packed in blister or strip packaging or in a container with a child-resistant closure; and
	(iii) in a primary pack of 25 or fewer dosage units; and
	(iv) the primary pack is labelled with warning statements to the following effect:
	Don't use [this product / name of the product] :
	If you have a stomach ulcer;
	In the last 3 months of pregnancy [This statement may be omitted in preparations used exclusively for the treatment of dysmenorrhoea] ;
	If you are allergic to ibuprofen or other anti-inflammatory medicines.
	Unless a doctor has told you to, don't use [this product / name of the product] :
	For more than a few days at a time;
	With other medicines containing ibuprofen or other anti-inflammatory medicines or other medicines that you are taking regularly;
	If you have asthma;
	In children 6 years of age or less;
	If you are aged 65 years or over;
	If you are pregnant [This statement may be omitted in preparations used exclusively for the treatment of dysmenorrhoea] .